1. Volume 143, Issue 2, Pages 246-251 (November 2016)
A comparison of overall survival with 40 and 50mg/m2 pegylated liposomal doxorubicin treatment in patients with recurrent epithelial ovarian cancer: Propensity score-matched analysis of real-world data 
Masahiko Nakayama, Hisanori Kobayashi, Tomihiro Takahara, Yukiko Nishimura, Koji Fukushima, Kazutake Yoshizawa 
Gynecologic Oncology 
Volume 143, Issue 2, Pages (November 2016)
DOI: /j.ygyno
Copyright © 2016 The Authors Terms and Conditions

2. Fig. 1 Patient flow diagram.
Gynecologic Oncology  , DOI: ( /j.ygyno )
Copyright © 2016 The Authors Terms and Conditions

3. Fig. 2
Overall survival of full dataset; green, PLD 50mg/m2; blue, PLD 40mg/m2.
Gynecologic Oncology  , DOI: ( /j.ygyno )
Copyright © 2016 The Authors Terms and Conditions

4. Fig. 3
Overall survival of propensity-score matched dataset; green, PLD 50mg/m2; blue, PLD 40mg/m2.
Gynecologic Oncology  , DOI: ( /j.ygyno )
Copyright © 2016 The Authors Terms and Conditions